Literature DB >> 32470328

Targeted Depletion of Bacteria from Mixed Populations by Programmable Adhesion with Antagonistic Competitor Cells.

See-Yeun Ting1, Esteban Martínez-García2, Shuo Huang1, Savannah K Bertolli1, Katherine A Kelly1, Kevin J Cutler3, Elizabeth D Su1, Hui Zhi4, Qing Tang1, Matthew C Radey1, Manuela Raffatellu5, S Brook Peterson1, Víctor de Lorenzo2, Joseph D Mougous6.   

Abstract

Selective and targeted removal of individual species or strains of bacteria from complex communities can be desirable over traditional, broadly acting antibacterials in several contexts. However, generalizable strategies that accomplish this with high specificity have been slow to emerge. Here we develop programmed inhibitor cells (PICs) that direct the potent antibacterial activity of the type VI secretion system (T6SS) against specified target cells. The PICs express surface-displayed nanobodies that mediate antigen-specific cell-cell adhesion to effectively overcome the barrier to T6SS activity in fluid conditions. We demonstrate the capacity of PICs to efficiently deplete low-abundance target bacteria without significant collateral damage to complex microbial communities. The only known requirements for PIC targeting are a Gram-negative cell envelope and a unique cell surface antigen; therefore, this approach should be generalizable to a wide array of bacteria and find application in medical, research, and environmental settings.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  community; interbacterial; microbiome; phage; probiotic

Mesh:

Substances:

Year:  2020        PMID: 32470328      PMCID: PMC7725374          DOI: 10.1016/j.chom.2020.05.006

Source DB:  PubMed          Journal:  Cell Host Microbe        ISSN: 1931-3128            Impact factor:   21.023


  54 in total

1.  Contact-dependent inhibition of growth in Escherichia coli.

Authors:  Stephanie K Aoki; Rupinderjit Pamma; Aaron D Hernday; Jessica E Bickham; Bruce A Braaten; David A Low
Journal:  Science       Date:  2005-08-19       Impact factor: 47.728

2.  The Type VI secretion system: a versatile bacterial weapon.

Authors:  Sarah Coulthurst
Journal:  Microbiology       Date:  2019-03-20       Impact factor: 2.777

3.  Crystal structure of enteropathogenic Escherichia coli intimin-receptor complex.

Authors:  Y Luo; E A Frey; R A Pfuetzner; A L Creagh; D G Knoechel; C A Haynes; B B Finlay; N C Strynadka
Journal:  Nature       Date:  2000-06-29       Impact factor: 49.962

4.  High-molecular-weight polymers from dietary fiber drive aggregation of particulates in the murine small intestine.

Authors:  Asher Preska Steinberg; Sujit S Datta; Thomas Naragon; Justin C Rolando; Said R Bogatyrev; Rustem F Ismagilov
Journal:  Elife       Date:  2019-01-22       Impact factor: 8.140

5.  Engineered toxin-intein antimicrobials can selectively target and kill antibiotic-resistant bacteria in mixed populations.

Authors:  Rocío López-Igual; Joaquín Bernal-Bayard; Alfonso Rodríguez-Patón; Jean-Marc Ghigo; Didier Mazel
Journal:  Nat Biotechnol       Date:  2019-04-15       Impact factor: 54.908

6.  Type VI secretion delivers bacteriolytic effectors to target cells.

Authors:  Alistair B Russell; Rachel D Hood; Nhat Khai Bui; Michele LeRoux; Waldemar Vollmer; Joseph D Mougous
Journal:  Nature       Date:  2011-07-20       Impact factor: 49.962

7.  NaLi-H1: A universal synthetic library of humanized nanobodies providing highly functional antibodies and intrabodies.

Authors:  Sandrine Moutel; Nicolas Bery; Virginie Bernard; Laura Keller; Emilie Lemesre; Ario de Marco; Laetitia Ligat; Jean-Christophe Rain; Gilles Favre; Aurélien Olichon; Franck Perez
Journal:  Elife       Date:  2016-07-19       Impact factor: 8.140

8.  Yeast surface display platform for rapid discovery of conformationally selective nanobodies.

Authors:  Conor McMahon; Alexander S Baier; Roberta Pascolutti; Marcin Wegrecki; Sanduo Zheng; Janice X Ong; Sarah C Erlandson; Daniel Hilger; Søren G F Rasmussen; Aaron M Ring; Aashish Manglik; Andrew C Kruse
Journal:  Nat Struct Mol Biol       Date:  2018-02-12       Impact factor: 15.369

9.  Conditional toxicity and synergy drive diversity among antibacterial effectors.

Authors:  Kaitlyn D LaCourse; S Brook Peterson; Hemantha D Kulasekara; Matthew C Radey; Jungyun Kim; Joseph D Mougous
Journal:  Nat Microbiol       Date:  2018-02-19       Impact factor: 17.745

10.  Human gut bacteria contain acquired interbacterial defence systems.

Authors:  Benjamin D Ross; Adrian J Verster; Elhanan Borenstein; Joseph D Mougous; Matthew C Radey; Danica T Schmidtke; Christopher E Pope; Lucas R Hoffman; Adeline M Hajjar; S Brook Peterson
Journal:  Nature       Date:  2019-10-30       Impact factor: 49.962

View more
  16 in total

1.  Targeted microbiome depletion.

Authors:  Andrea Du Toit
Journal:  Nat Rev Microbiol       Date:  2020-08       Impact factor: 60.633

2.  Structural basis for effector transmembrane domain recognition by type VI secretion system chaperones.

Authors:  Kara K Tsang; Kartik Sachar; Shehryar Ahmad; Dennis Quentin; Tahmid M Tashin; Nathan P Bullen; Stefan Raunser; Andrew G McArthur; Gerd Prehna; John C Whitney
Journal:  Elife       Date:  2020-12-15       Impact factor: 8.140

3.  Antimicrobial Weapons of Pseudomonas aeruginosa.

Authors:  Laura M Nolan; Luke P Allsopp
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 3.650

4.  Strain-level functional variation in the human gut microbiota based on bacterial binding to artificial food particles.

Authors:  Michael L Patnode; Janaki L Guruge; Juan J Castillo; Garret A Couture; Vincent Lombard; Nicolas Terrapon; Bernard Henrissat; Carlito B Lebrilla; Jeffrey I Gordon
Journal:  Cell Host Microbe       Date:  2021-02-10       Impact factor: 21.023

Review 5.  Potential of Skin Microbiome, Pro- and/or Pre-Biotics to Affect Local Cutaneous Responses to UV Exposure.

Authors:  VijayKumar Patra; Irène Gallais Sérézal; Peter Wolf
Journal:  Nutrients       Date:  2020-06-17       Impact factor: 5.717

6.  Endogenous membrane stress induces T6SS activity in Pseudomonas aeruginosa.

Authors:  Anne-Sophie Stolle; Bradley Thomas Meader; Jonida Toska; John J Mekalanos
Journal:  Proc Natl Acad Sci U S A       Date:  2020-12-21       Impact factor: 11.205

7.  Co-infection of Malassezia sympodialis With Bacterial Pathobionts Pseudomonas aeruginosa or Staphylococcus aureus Leads to Distinct Sinonasal Inflammatory Responses in a Murine Acute Sinusitis Model.

Authors:  Keehoon Lee; Irene Zhang; Shari Kyman; Oliver Kask; Emily Kathryn Cope
Journal:  Front Cell Infect Microbiol       Date:  2020-09-04       Impact factor: 5.293

Review 8.  Perspectives on how mucosal immune responses, infections and gut microbiome shape IgA nephropathy and future therapies.

Authors:  Jia-Wei He; Xu-Jie Zhou; Ji-Cheng Lv; Hong Zhang
Journal:  Theranostics       Date:  2020-09-15       Impact factor: 11.556

Review 9.  Understanding the gut microbiota and sarcopenia: a systematic review.

Authors:  Chaoran Liu; Wing-Hoi Cheung; Jie Li; Simon Kwoon-Ho Chow; Jun Yu; Sunny Hei Wong; Margaret Ip; Joseph Jao Yiu Sung; Ronald Man Yeung Wong
Journal:  J Cachexia Sarcopenia Muscle       Date:  2021-09-14       Impact factor: 12.910

10.  Proteus mirabilis Employs a Contact-Dependent Killing System against Competing Enterobacteriaceae.

Authors:  Dara Kiani; William Santus; Kaitlyn A Kiernan; Judith Behnsen
Journal:  mSphere       Date:  2021-07-28       Impact factor: 4.389

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.